medline.ch Onkologie Gynäkologische Tumoren

	Recent advances in non-pharmacological interventions for symptom burden management in breast cancer patients treated with ovarian function suppression. Support Care Cancer Li Y, Chen Y, Wang S, Wang X, Xing Y, Wu Q, Fang Q. PMID: 41680554 [PubMed - indexed for MEDLINE]
	Determinants and outcomes of ovarian cancer diagnosis following an emergency presentation: a systematic review. Int J Gynecol Cancer Zachou G, Rongali S, Wu R, van der Meulen J, Gurol-Urganci I, Hutchings A, Michael A, Sundar S. PMID: 41680020 [PubMed - as supplied by publisher]
	Targeting RAS-RAF-MEK-ERK signaling in mucinous ovarian cancer: a translational evidence synthesis and clinical framework. Int J Gynecol Cancer Bartl T, Cacsire Castillo-Tong D. PMID: 41680018 [PubMed - as supplied by publisher]
	InÂ Vivo Studies of [(161)Tb]Tb-Trastuzumab Radiopharmaceutical Therapy in Human Epidermal Growth Factor Receptor 2-Expressing Breast Tumors Show High Tumor Uptake and Tumor Growth Suppression. J Nucl Med Cold S, Sadasivam P, Wessel MM, Ischyropoulou M, Fonslet J, Engel TB, Nielsen CH, Kjaer A, Kristensen LK. PMID: 41679917 [PubMed - as supplied by publisher]
	Development of lignin-based nanoparticles using green chemistry for targeted delivery of doxorubicin to breast cancer cells: In-silico and in-vitro study. Int J Biol Macromol Firdaus M, Azzahra FPD, Rohmah M, Widayat SB, Nabilla K, Husna N, Wibowo FR. PMID: 41679480 [PubMed - as supplied by publisher]
	Structural reprogramming of irradiated ellagic acid suppresses cell cycle regulators and modulates cytokines via activation of the p53/BAX-CASP3/Bcl-2-cyclin D1 pathway: Validation studies across breast cancer cell lines. Int J Biol Macromol Eldairy HM, Mosallam SAE, Elmetwalli A. PMID: 41679479 [PubMed - as supplied by publisher]
	Study on the characteristics and influencing factors of learned helplessness in breast cancer patients undergoing chemotherapy: A latent class analysis. Acta Psychol (Amst) Li X, Jiao Y, Guo Z, Lu Y, Huang Y, Shen X, Chen C. PMID: 41679153 [PubMed - as supplied by publisher]
	Feasibility and preliminary outcomes of a Rebuilding Osteo Strength with Exercise (ROSE) program for women with breast cancer undergoing endocrine therapy. Eur J Oncol Nurs Chen L, Zhao Y, Yang A, Bai L, Thomas TH, Zhao F, Liu Y, Liu JE, Gao F. PMID: 41679121 [PubMed - as supplied by publisher]
	Survival benefit of platinum-based chemotherapy in non-surgically treated advanced ovarian cancer: A nationwide study. Gynecol Oncol Garkhail P, de Bruin PC, Boere IA, van der Aa MA, van Driel WJ, van Beekhuizen HJ, de Boer GMN. PMID: 41679114 [PubMed - as supplied by publisher]
	NMR spectroscopy stability studies of Ru-IM, a prodrug candidate for triple negative breast cancer. J Inorg Biochem Mayrata M, Lopez-Sanchez A, Urriolabeitia EP, McCarrick S, Manu A, López-Hernández JE, Neary MC, Contel M. PMID: 41679112 [PubMed - as supplied by publisher]
	Treatment of ER-positive breast cancer with FDA-approved aromatase inhibitors. Cancer Treat Res Commun Kim N, Lukong KE. PMID: 41678931 [PubMed - as supplied by publisher]
	Anthropometric and biochemical nutritional indicators and survival in women with breast cancer: A retrospective cohort study. PLoS One Sánchez-Saldaña L, Lozada-Urbano M, Sullcahuaman-Allende Y, Cotrina-Concha J, Velarde-Méndez M, Chavez-Chocano J, Rodríguez-Coyla E, Zambrano-Jaimes L, Mantilla-Quispe R, Rosales-Rimache J. PMID: 41678559 [PubMed - indexed for MEDLINE]
	Al18F-NOTA-FAPI-04 PET/CT for diagnosis of breast cancer and its correlation with pathological features: A single-center retrospective study. PLoS One Wang Y, Feng L, He L, Liu N, Wang H. PMID: 41678503 [PubMed - indexed for MEDLINE]
	Sleep, Depressive Symptoms, and Quality of Life Among Women With Newly Diagnosed Breast Cancer: Baseline Results From the AMBER Cohort Study. Cancer Med Yang L, Tayyab T, Kokts-Porietis RL, Wang Q, McNeil J, Matthews CE, Dickau L, Vallance JK, McNeely ML, Culos-Reed SN, Kopciuk KA, Courneya KS, Friedenreich CM. PMID: 41678369 [PubMed - indexed for MEDLINE]
	Addressing the Challenges in the Identification of HER2-Low and Ultralow Breast Cancer in Asia: A Delphi Consensus. Adv Ther Shah M, Yolo RT, Hernowo BS, Cong TN, Gyungyub G, Irianiwati, Kim LB, Madrid MA, Rajadurai P, Sampatanukul P, Ueng SH, Pasricha S, Tan BY, Tan PH, Jitpasutham T. PMID: 41678134 [PubMed - as supplied by publisher]
	Muscle quality during cancer treatment and associations with health-related quality of life. Qual Life Res Rodrigues JL, O'Connell NS, Sutton AL, Ruddy KJ, Weaver KE, Lesser GJ, Ky B, D'Agostino RB Jr, Hundley WG, Bellissimo MP. PMID: 41678067 [PubMed - indexed for MEDLINE]
	Understanding, Recognizing, and Managing Cancer-Related Fatigue Associated with Breast Cancer. Curr Treat Options Oncol Peng L, Wang X, Zhang C, Liu T, Luo X, Li Z. PMID: 41678031 [PubMed - in process]
	Axillary Extranodal Extension in Breast Cancer: Imaging Features With Histopathology Correlation. J Breast Imaging Nguyen PT, Portnow LH, Packer MD, Gombos EC. PMID: 41677770 [PubMed - as supplied by publisher]
	Extracellular Vesicle Associated Proteomic Biomarkers in Breast Cancer: A Systematic Review and Meta-Analysis. Cells Al-Mahrouqi N, Al-Sayegh H, Al-Zadjali S, Khan AA. PMID: 41677598 [PubMed - indexed for MEDLINE]
	Prevalence of BRCA1 and BRCA2 Germline Mutations in Vietnamese Patients With Triple-Negative Breast Cancer. Cancer Control Toan TT, To TV, Lan TTH, Thinh NV, Anh DTN, Hanh BTM. PMID: 41676859 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 324325

Seite 1 von 16217

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung